Marine L Andersson
Overview
Explore the profile of Marine L Andersson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hammar T, Jonsen E, Bjorneld O, Askfors Y, Andersson M, Lincke A
Pharmacy (Basel)
. 2024 Nov;
12(6).
PMID: 39585094
Adverse drug events (ADEs) occur frequently and are a common cause of suffering, hospitalizations, or death, and can be caused by harmful combinations of medications. One method used to prevent...
2.
Bischof T, Schaller C, Buchtele N, Staudinger T, Ullrich R, Kraft F, et al.
Pharmaceutics
. 2024 Mar;
16(3).
PMID: 38543197
Acute respiratory distress syndrome (ARDS) is a potential life-threatening, heterogenous, inflammatory lung disease. There are no data available on potential drug-drug interactions (pDDIs) in critically ill patients with ARDS. This...
3.
Petersson L, Schorgenhofer C, Askfors Y, Justad H, Dahl M, Andersson M
Drugs Aging
. 2023 Apr;
40(4):369-376.
PMID: 37039960
Background: Polypharmacy in older people is steadily increasing and a combination of many medicines may result in adverse effects, especially if the medicines interact pharmacodynamically. Examples are additive or synergistic...
4.
Patients' Use and Perceptions of a Drug-Drug Interaction Database: A Survey of Janusmed Interactions
Justad H, Askfors Y, Shemeikka T, Andersson M, Hammar T
Pharmacy (Basel)
. 2021 Jan;
9(1).
PMID: 33478093
Janusmed interactions is a drug-drug interactions (DDI) database available online for healthcare professionals (HCP) at all levels of the healthcare system including pharmacies. The database is aimed at HCP but...
5.
Hoffmann M, Vander Stichele R, Bates D, Bjorklund J, Alexander S, Andersson M, et al.
Expert Rev Clin Pharmacol
. 2020 Sep;
13(9):925-934.
PMID: 32990065
Introduction: Technical and logical breakthroughs have provided new opportunities in medicine to use knowledge bases and large-scale clinical data (real-world) at point-of-care as part of a learning healthcare system to...
6.
Andersson M, Mannheimer B, Lindh J
Eur J Clin Pharmacol
. 2019 Jun;
75(10):1387-1392.
PMID: 31201436
Purpose: Some data indicate that simvastatin may increase the anticoagulative effect in patients treated with warfarin, but the evidence is scarce. The aim of the present study was to investigate...
7.
Hedna K, Andersson M, Gyllensten H, Hagg S, Bottiger Y
BMC Geriatr
. 2019 Jun;
19(1):164.
PMID: 31185943
Background: PHARAO is a decision support system developed to evaluate the risk for a set of either common or serious side-effects resulting from a combination of pharmacodynamic effects from a...
8.
Jarnbert-Pettersson H, Andersson M, Bilen K, Brostrom O, Lindh J, Mannheimer B
PLoS One
. 2019 Apr;
14(4):e0215356.
PMID: 30995259
Aims: Tramadol, a widely used analgesic drug, inhibits the reuptake of noradrenaline and serotonin impairing the aggregation function of thrombocytes. However, the risk for severe bleeding has previously not been...
9.
Bottiger Y, Laine K, Korhonen T, Lahdesmaki J, Shemeikka T, Julander M, et al.
Eur J Clin Pharmacol
. 2017 Dec;
74(3):365-371.
PMID: 29198061
Purpose: The aims of this study are to describe the development of PHARAO (Pharmacological Risk Assessment Online), a decision support system providing a risk profile for adverse events, associated with...
10.
Andersson M, Bottiger Y, Kockum H, Eiermann B
Basic Clin Pharmacol Toxicol
. 2017 Nov;
122(5):512-516.
PMID: 29143454
Drug-drug interactions are increasingly common, as patients are getting older and the number of drugs per patient is increasing. In this study, we investigated to which extent potential drug-drug interactions...